P
Philippe Moreau
Researcher at University of Nantes
Publications - 693
Citations - 52995
Philippe Moreau is an academic researcher from University of Nantes. The author has contributed to research in topics: Multiple myeloma & Medicine. The author has an hindex of 104, co-authored 517 publications receiving 42530 citations. Previous affiliations of Philippe Moreau include University of Grenoble & National and Kapodistrian University of Athens.
Papers
More filters
Journal ArticleDOI
Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis.
Ludivine Morvan,Thomas Carlier,Bastien Jamet,Clément Bailly,Caroline Bodet-Milin,Philippe Moreau,Françoise Kraeber-Bodéré,Diana Mateus +7 more
TL;DR: The results confirm the predictive value of radiomics for MM patients, in particular, they demonstrate that quantitative/heterogeneity image-based features reduce the error of the predicted progression.
Journal ArticleDOI
Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups
Patricia Gomez-Bougie,Maxime Halliez,Sophie Maïga,Catherine Godon,Charlotte Kervoëlen,Catherine Pellat-Deceunynck,Philippe Moreau,Martine Amiot +7 more
TL;DR: It is shown that primary myeloma cells were also sensitive to curcumin, even those displaying del(17p), another poor prognosis factor, and the contribution of anti-apoptotic Bcl-2 family molecules in Curcumin response is unraveled.
Journal ArticleDOI
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.
Paula Rodriguez-Otero,Sikander Ailawadhi,Bertrand Arnulf,Krina K. Patel,Michele Cavo,Ajay K. Nooka,Salomon Manier,Natalie S. Callander,Luciano J. Costa,Ravi Vij,Nizar J. Bahlis,Philippe Moreau,Scott D. Solomon,Michel Delforge,Jesus G. Berdeja,Anna Truppel-Hartmann,Zhihong Yang,Linda Favre-Kontula,Fan Wu,Julia C. Piasecki,Mark J. Cook,Sergio Giralt +21 more
TL;DR: In this paper , the authors showed that ide-cel therapy significantly prolonged progression-free survival and improved response as compared with standard regimens in patients with relapsed and refractory multiple myeloma who had received two to four regimens previously.
Journal ArticleDOI
Single-shot hybrid photoacoustic-fluorescent microendoscopy through a multimode fiber with wavefront shaping.
Sylvain Mezil,Antonio M. Caravaca-Aguirre,Edward Z. Zhang,Philippe Moreau,Irène Wang,Paul C. Beard,Emmanuel Bossy +6 more
TL;DR: A minimally-invasive endoscope based on a multimode fiber that combines photoacoustic and fluorescence sensing and the high signal-to-noise ratio provided by wavefront shaping based focusing enables imaging with a single laser shot per pixel, demonstrating fast two-dimensional hybrid in vitro imaging of red blood cells and fluorescent beads.
Journal ArticleDOI
The emerging role of carfilzomib combination therapy in the management of multiple myeloma
TL;DR: Single-agent carfilzomib has produced robust and durable responses in clinical trials and it has been approved in the US for treating relapsed and refractory multiple myeloma.